Hydroponic Cultivation in Systemic Nickel Allergy Syndrome

Not Applicable

Completed

• Conditions: Food Hypersensitivity; Nickel Sensitivity; Food Allergy
• Interventions: Other: Datterino tomato puree from conventional cultivation; Other: Datterino tomato purée from hydroponic technology

• Registration Number: NCT05232890
• Lead Sponsor: Catholic University of the Sacred Heart

Brief Summary

Oral intake of nickel (Ni) is capable of causing the onset of systemic disorders in patients with Systemic Allergy to Nickel Syndrome (SNAS), an emerging allergic condition. Given its ubiquitous age, it is not possible to completely eliminate Ni and, therefore, it is necessary to plan a low-content diet. However, due to various factors (such as variability of Ni concentration in the soil, individual foods, variability of dietary habits and daily menus, different intake of Ni contained in the water, different intake of kitchen utensils, simultaneous intake of other substances), a restrictive diet is difficult and socially discriminating with a strongly negative impact on the quality of life of these patients.

Hydroponic agriculture in a completely controlled, aseptic, artificial, soilless environment could be an alternative for patients suffering from SNAS with known and lower concentrations of metals than those deriving from conventional agricultural techniques, which are affected by the soil of origin and practices cultivation.

The primary outcome of the study is to evaluate the possible effects of taking tomato puree deriving from hydroponic agriculture compared to tomato puree from conventional cultivation in the subjective control of SNAS symptoms, in patients following a low-diet diet.

This is an interventional, randomized, double-blind, single-center crossover study involving a cohort of SNAS patients following a low-nickel diet for at least 4-6 weeks.

Detailed Description

Not available

Study Timeline

• Study Start: 2021-02-26
• Study First Submitted: 2021-11-17
• Study First Submitted QC: 2022-01-31
• Study First Posted: 2022-02-10
• Primary Completion: 2022-02-28
• Study Completion: 2022-03-31
• Status Verified: 2022-04
• Last Update Submitted: 2022-04-02
• Last Update Posted: 2022-04-05

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 30

Inclusion Criteria

• Patients with documented diagnosis of SNAS: a) history of SNAS (coexistence of typical skin symptoms and gastrointestinal symptoms); b) positive nickel sulphate patch test; c) clinical improvement of at least 70% after 4-6 weeks of low-nickel diet; d) positivity of the oral challenge test with nickel sulphate.
• Age between 18 and 65 years.
• Written informed consent to participate in the study.
• Patients who are able to participate in all study procedures and to accept and comply with all study needs throughout the study, including the availability of suitable transportation and the time required to undergo all procedures. planned visits.

Exclusion Criteria

• Women who are pregnant or breastfeeding.
• Patients diagnosed with organic diseases capable of affecting gastrointestinal symptoms (eg celiac disease, poorly controlled diabetes, scleroderma, chronic inflammatory bowel diseases). Lactose intolerance is not an exclusion criterion if the diagnosis has been made for more than 6 months and if the patient does not report adequate symptom relief after at least 6 months of a lactose-free diet.
• Patients who have been taking systemic probiotics, antibiotics or systemic corticosteroids within the past 30 days.
• Patients who have been taking antidepressant or anxiolytic drugs for less than a month. On the other hand, patients can be enrolled who have been taking the aforementioned drugs at a stable dosage for at least one month.
• Patients who abuse coffee, tea, coca cola and with a smoking habit.
• Patients with pacemakers because they cannot be subjected to bioimpedance analysis for the assessment of body composition.

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: CROSSOVER

Arm && Interventions

Group	Intervention	Description
Datterino tomato purée from conventional cultivation	Datterino tomato puree from conventional cultivation	100% Italian datterino tomato purée deriving from conventional cultivation.
Datterino tomato purée from hydroponic technology	Datterino tomato purée from hydroponic technology	100% Italian datterino tomato purée deriving from hydroponic technology (soilless) with particular characteristics such as nickel free and zero residue.

Primary Outcome Measures

Name	Time	Method
Change of gastrointestinal symptoms control	Immediately after the intervention	Average values of the scores relating to the individual SNAS symptoms as reported in the visual analogue scale (VAS) - Systemic Nickel Allergy Syndrome (SNAS) scale before and after taking each type of tomato sauce (hydroponic vs conventional).; This scale includes values from a minimum of zero to a maximum of ten. Higher scores indicate a worse outcome.

Secondary Outcome Measures

Name	Time	Method
Change of impact on quality of life - SF-36	Change from baseline index at 12 and 26 weeks.	Difference in mean scores on quality of life questionnaire Short Form 36 Items Health Survey (SF-36) before and after each planned dietary treatment (hydroponic vs conventional tomato).; Each patient answers SF-36v2 (Italian version) questionnaire. It comprises 36-items measuring 8 dimensions of general QoL. Each question's score is coded, summed up, and transformed to a scale of 0 (worst possible health state measured by the questionnaire) to 100 (best possible health state).
Change of impact on quality of life - PGWBI	Change from baseline index at 12 and 26 weeks.	Difference in mean scores on quality of life questionnaire Psychological General Well Being Index (PGWBI) before and after each planned dietary treatment (hydroponic vs conventional tomato).; PGWBI consists of 22 questions, which deal with 6 factors (anxiety, depression, vitality, general health,self-control and well-being) constituting a global assessment. The response format is graded 1-6. This index includes values from a minimum of 0 to a maximum of 110. Higher scores indicate a better outcome.
Change of ferritin	Change from baseline index at 12 and 26 weeks.	Difference in the average values of ferritin \[ng/ml\] before and after each planned dietary treatment (hydroponic vs conventional tomato puree).
Change of intestinal permeability	Change from baseline index at 12 and 26 weeks.	Difference in mean values of serum zonulin (a biomarker of intestinal permeability) before and after each planned dietary treatment (hydroponic vs conventional tomato puree).
Change of Vitamin D	Change from baseline index at 12 and 26 weeks.	Difference in the average values of Vitamin D \[ng/ml\] before and after each planned dietary treatment (hydroponic vs conventional tomato puree).
Change of beta-carotene	Change from baseline index at 12 and 26 weeks.	Difference in the average values of beta-carotene \[microg/dl\] before and after each planned dietary treatment (hydroponic vs conventional tomato puree).
Change of hemoglobin	Change from baseline index at 12 and 26 weeks.	Difference in the average values of hemoglobin \[g/dl\] before and after each planned dietary treatment (hydroponic vs conventional tomato puree).
Change of adherence	After 12 weeks, after 26 weeks.	Cross-comparison between the percentages of weekly intake \[average number of days per week\] of tomato puree (hydroponic tomato puree before and conventional after versus conventional tomato puree before and hydroponic after).

Trial Locations

Locations (1)

UOSD Allergologia e Immunologia Clinica, Fondazione Policlinico Universitario A. Gemelli IRCCS; 🇮🇹 Roma, Italy